These findings can be attributed to an aberrant over-expression of interleukin 17A, a cytokine with a key role in the pathogenesis of psoriatic disease, which also seems to be crucial in the pathogenesis of metabolic syndrome, since it is clearly associated with insulin resistance and desensitization of insulin receptors in the liver and in muscle tissue. The gene discussed is IL17A; the disease is metabolic syndrome.